When should I start losing weight on Wegovy — and what to expect

Why don't most people lose weight immediately on Wegovy?

This is one of the most common questions our prescribers hear, and there is a reasonable misconception buried in it, people often assume the first injection starts working right away in the way a painkiller might. Wegovy does not work like that. The 0.25 mg starting dose is calibrated for tolerability, helping your gut and nervous system get used to semaglutide before the dose climbs. At that level, appetite suppression is mild and the hormonal effects on gastric emptying are subtle. Noticeable hunger reduction tends to arrive as the dose increases through 0.5 mg and 1.0 mg, and it becomes more consistent at 1.7 mg and 2.4 mg.

The titration schedule (moving up roughly every four weeks) means most people reach the standard 2.4 mg maintenance dose somewhere around the five-month mark. That is when the bulk of the clinical-trial weight loss was recorded. So if you are in the early weeks and the scales have barely shifted, that is not a sign the medicine is not working. It is the medicine doing exactly what it is supposed to do first: settle in. You can read more about when Wegovy typically starts working and what the early weeks feel like physiologically.

The NHS medicines page for semaglutide explains the dose escalation pattern and what to expect at each stage.

When do most people actually start losing weight on Wegovy?

Broadly, there are two phases. In the first four to eight weeks, some people see a small drop (often two to four pounds) driven partly by reduced calorie intake as appetite falls and partly by changes in fluid balance and gut transit. This early movement can be encouraging, but it is not representative of the longer-term picture.

The more sustained weight loss tends to arrive from around months two to four, as the dose climbs and appetite suppression becomes reliable day to day. By the time someone reaches the 2.4 mg maintenance dose and has been on it for a further eight to twelve weeks, the cumulative effect is usually clear. The STEP 1 trial, published in the New England Journal of Medicine, tracked 68 weeks of treatment and found an average body-weight reduction of around 15%, which underlines that this is a sustained, months-long process rather than a rapid one.

It is also worth knowing that weight loss is rarely linear. Plateaus are common, particularly after the first rush of appetite change settles into a new normal. That is not a sign to stop; it is a sign to check in with your prescriber about diet, activity, and whether anything needs adjusting. For a broader look at the semaglutide experience, our semaglutide overview covers the clinical background in detail.

What affects how quickly you lose weight on Wegovy?

Starting weight plays a role: people with a higher BMI at baseline often see a larger absolute number on the scales early on, though the percentage reduction tends to equalise over time. Age, metabolic rate, sleep quality, stress, and whether a reduced-calorie diet is genuinely maintained all influence outcomes. Wegovy is licensed for use alongside dietary changes and increased activity, it works with those habits, not instead of them.

Gastrointestinal side effects (nausea, reflux, loose stools) are common in the first weeks and can temporarily reduce appetite in ways that inflate early weight loss figures. Once those symptoms settle, the rate of loss may appear to slow even though the medicine is working steadily. This catches some people off guard. If you are wondering how the semaglutide experience compares week to week, how quickly people typically lose weight on Wegovy goes into the data in more detail.

Cost is a practical factor too, if affordability is a concern, what Wegovy actually costs in the UK lays out what a legitimate private prescription includes and what to watch out for.

Should I be worried if I haven't lost weight after a few weeks on Wegovy?

Not at the starter dose, no. If you want a clearer picture of when you can expect to start losing weight on Wegovy, it helps to understand that the four-to-eight-week mark at 0.25 mg is genuinely too early to draw conclusions. Even by month two or three, individual variation is wide enough that a slow start does not predict a poor outcome at month six. The clinical guidance from NICE (in its appraisal of semaglutide, TA875) sets the formal review point at six months on the maintenance dose: if weight loss is less than 5% by then, continuing should be reconsidered. That is the threshold worth keeping in mind, not what the scales say in week three.

A prescriber should know if you feel the medicine is not having any effect after several months at a higher dose, or if side effects are making it hard to maintain any dietary changes. Reaching out to your clinical team is always the right move before stopping or changing anything. If you are still working out whether Wegovy is the right fit for your situation, our Wegovy page and the broader weight-loss treatments overview are good places to get oriented before a consultation.

Whenever you are ready to speak to a prescriber, start your free consultation with our team, a real clinician reviews your case the same day.